Top compounds associated with response to LINC01125


Feature Type Standardized
Nominal ANOVA
mRNA RAF265 CTRPv2 pan-cancer AAC -0.04 0.3
mRNA CD-437 CTRPv2 pan-cancer AAC 0.031 0.3
mRNA spautin-1 CTRPv2 pan-cancer AAC 0.036 0.3
mRNA BRD-K52037352 CTRPv2 pan-cancer AAC 0.039 0.3
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.032 0.3
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.031 0.3
mRNA BRD4132 CTRPv2 pan-cancer AAC 0.036 0.4
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.4
mRNA PLX4720 CCLE pan-cancer AAC -0.041 0.4
mRNA Nilotinib CCLE pan-cancer AAC -0.046 0.4
Download CSV